The SPAPLUS is a fully automated, high throughput, easy-to-use, bench top, turbidimetric protein analyzer for serum, plasma, and urine assays including Freelite®, IgG subclasses, IgA subclasses, IgG, IgA, IgM, IgD, Cystatin C, C3, C4, β2 Microglobulin, Albumin, Haptoglobin, Prealbumin, and an expanding range of new assays under development.

With its expanding menu, the SPAPLUS System enables laboratories to maintain the quality of results and high throughput of specialized protein assays while transferring the more routine high volume assays to large chemistry analyzers. 

The flexibility and versatility of the SPAPLUS System and its small footprint make it an ideal companion analyzer to your automated chemistry line as well as your special chemistry testing. 

Read what our customers have experienced:

“We installed and validated the SPAPLUS Analyzer here at CPL--Austin main laboratory to replace the Siemens BN-II for Serum Free Light Chain assays. The system has performed beautifully with little or no down time since it went on line. The technical staff testify that it is a great improvement for our laboratory with several qualities including:

·         Improved overall efficiency
·         Ease of use
·         Faster overall through-put
·         Less sample volume required
·         No “pro-zone” issues with the system's antigen access checking

Our clients are happy, and our volume has increased since we brought this assay in-house. We would highly recommend this system to other laboratories for these assays.” M. Callaway, M.T.(ASCP)

* * *

"The SPAPLUS has been able to handle smaller pipetting volumes, and it has provided greater consistency in the reporting of the serum free light chain results than our previous platform, the IMMAGE.

The serum free light chain ratio offers the best opportunity for "real time" monitoring of many patients with serum paraproteins given the relatively short half-life of a free light chain versus a complete paraprotein.

In addition, the increased sensitivity has enhanced detection of plasma cell neoplasms such as plasma cell myeloma but also some lymphoproliferative disorders, especially those that might go undetected because of a negative serum protein electrophoresis and or serum immunofixation study.  

The serum free light chain study is a truly quantitative study, and it is generally easier to interpret than serum protein electrophoresis and serum immunofixation studies.

In most instances the serum free light chain test has obviated the need for urine protein electrophoresis and urine immunofixation studies.” L. Johnson, MD, FCAP, FASCP

Characteristics

Specifications

Immunoassays on SPAPLUS